Literature DB >> 19237042

Congenital cardiac disease in the newborn infant: past, present, and future.

Sharyl L Sadowski1.   

Abstract

Congenital heart defects are the most common of all congenital malformations, with a review of the literature reporting the incidence at 6 to 8 per 1000 live births. The Centers for Disease Control reports cyanotic heart defects occurred in 56.9 per 100,000 live births in the United States in 2005, with higher rates noted when maternal age exceeded 40 years. The incidence of congenital heart disease in premature infants is 12.5 per 1000 live births, excluding isolated patent ductus arteriosus and atrial septal defect. Despite advances in detection and treatment, congenital heart disease accounts for 3% of all infant deaths and 46% of death from congenital malformations. This article discusses the embryology, pathogenesis, clinical presentation, incidence, classifications, and management of congenital heart diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19237042     DOI: 10.1016/j.ccell.2008.10.001

Source DB:  PubMed          Journal:  Crit Care Nurs Clin North Am        ISSN: 0899-5885            Impact factor:   1.326


  26 in total

1.  Correlation between GATA4 gene polymorphism and congenital heart disease.

Authors:  Xue-Yong Yang; Xiao-Yong Jing; Zhe Chen; Ying-Long Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  Probing human cardiovascular congenital disease using transgenic mouse models.

Authors:  Paige Snider; Simon J Conway
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

3.  Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery.

Authors:  Wen-fang Xia; Yu Liu; Qing-shan Zhou; Qi-zhu Tang; Han-dong Zou
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

4.  Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease.

Authors:  Ting Peng; Li Wang; Shu-Feng Zhou; Xiaotian Li
Journal:  Genetica       Date:  2010-11-26       Impact factor: 1.082

5.  A Case Study of Infant Physiologic Response to Skin-to-Skin Contact After Surgery for Complex Congenital Heart Disease.

Authors:  Tondi M Harrison; Susan Ludington-Hoe
Journal:  J Cardiovasc Nurs       Date:  2015 Nov-Dec       Impact factor: 2.083

6.  Hydrogen sulfide upregulates heme oxygenase-1 expression in rats with volume overload-induced heart failure.

Authors:  Chao-Ying Zhang; Xiao-Hui Li; Ting Zhang; Jin Fu; Xiao-Dai Cui
Journal:  Biomed Rep       Date:  2013-03-26

7.  The Association among Feeding Mode, Growth, and Developmental Outcomes in Infants with Complex Congenital Heart Disease at 6 and 12 Months of Age.

Authors:  Barbara Medoff-Cooper; Sharon Y Irving; Alexandra L Hanlon; Nadya Golfenshtein; Jerilynn Radcliffe; Virginia A Stallings; Bradley S Marino; Chitra Ravishankar
Journal:  J Pediatr       Date:  2015-11-13       Impact factor: 4.406

8.  Hydrogen sulfide suppresses the expression of MMP-8, MMP-13, and TIMP-1 in left ventricles of rats with cardiac volume overload.

Authors:  Chao-Ying Zhang; Xiao-Hui Li; Ting Zhang; Jin Fu; Xiao-Dai Cui
Journal:  Acta Pharmacol Sin       Date:  2013-08-26       Impact factor: 6.150

Review 9.  Supporting Optimal Neurodevelopmental Outcomes in Infants and Children With Congenital Heart Disease.

Authors:  Jennifer K Peterson
Journal:  Crit Care Nurse       Date:  2018-06       Impact factor: 1.708

10.  Association between maternal exposure to housing renovation and offspring with congenital heart disease: a multi-hospital case-control study.

Authors:  Zhen Liu; Xiaohong Li; Nana Li; Shengli Li; Kui Deng; Yuan Lin; Xinlin Chen; Fengzhi You; Jun Li; Dezhi Mu; Yanping Wang; Jun Zhu
Journal:  Environ Health       Date:  2013-03-25       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.